363 related articles for article (PubMed ID: 14754412)
1. Structure of multidrug-resistance proteins of the ATP-binding cassette (ABC) superfamily.
Altenberg GA
Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):53-62. PubMed ID: 14754412
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships.
Di Pietro A; Dayan G; Conseil G; Steinfels E; Krell T; Trompier D; Baubichon-Cortay H; Jault J
Braz J Med Biol Res; 1999 Aug; 32(8):925-39. PubMed ID: 10454753
[TBL] [Abstract][Full Text] [Related]
3. ATP-induced conformational changes of nucleotide-binding domains in an ABC transporter. Importance of the water-mediated entropic force.
Hayashi T; Chiba S; Kaneta Y; Furuta T; Sakurai M
J Phys Chem B; 2014 Nov; 118(44):12612-20. PubMed ID: 25302667
[TBL] [Abstract][Full Text] [Related]
4. The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR).
Teodori E; Dei S; Martelli C; Scapecchi S; Gualtieri F
Curr Drug Targets; 2006 Jul; 7(7):893-909. PubMed ID: 16842220
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance ABC transporters.
Chang G
FEBS Lett; 2003 Nov; 555(1):102-5. PubMed ID: 14630327
[TBL] [Abstract][Full Text] [Related]
6. Conformational coupling of the nucleotide-binding and the transmembrane domains in ABC transporters.
Wen PC; Tajkhorshid E
Biophys J; 2011 Aug; 101(3):680-90. PubMed ID: 21806936
[TBL] [Abstract][Full Text] [Related]
7. Role of the breast cancer resistance protein (ABCG2) in drug transport.
Mao Q; Unadkat JD
AAPS J; 2005 May; 7(1):E118-33. PubMed ID: 16146333
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of ABC transporters: a molecular dynamics simulation of a well characterized nucleotide-binding subunit.
Jones PM; George AM
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12639-44. PubMed ID: 12237398
[TBL] [Abstract][Full Text] [Related]
9. Substrate-induced conformational changes in the nucleotide-binding domains of lipid bilayer-associated P-glycoprotein during ATP hydrolysis.
Zoghbi ME; Mok L; Swartz DJ; Singh A; Fendley GA; Urbatsch IL; Altenberg GA
J Biol Chem; 2017 Dec; 292(50):20412-20424. PubMed ID: 29018094
[TBL] [Abstract][Full Text] [Related]
10. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.
Shukla S; Robey RW; Bates SE; Ambudkar SV
Drug Metab Dispos; 2009 Feb; 37(2):359-65. PubMed ID: 18971320
[TBL] [Abstract][Full Text] [Related]
11. Cysteine-scanning mutagenesis provides no evidence for the extracellular accessibility of the nucleotide-binding domains of the multidrug resistance transporter P-glycoprotein.
Blott EJ; Higgins CF; Linton KJ
EMBO J; 1999 Dec; 18(23):6800-8. PubMed ID: 10581253
[TBL] [Abstract][Full Text] [Related]
12. New light on multidrug binding by an ATP-binding-cassette transporter.
Shilling RA; Venter H; Velamakanni S; Bapna A; Woebking B; Shahi S; van Veen HW
Trends Pharmacol Sci; 2006 Apr; 27(4):195-203. PubMed ID: 16545467
[TBL] [Abstract][Full Text] [Related]
13. Targeting Nucleotide Binding Domain of Multidrug Resistance-associated Protein-1 (MRP1) for the Reversal of Multi Drug Resistance in Cancer.
Dhasmana D; Singh A; Shukla R; Tripathi T; Garg N
Sci Rep; 2018 Aug; 8(1):11973. PubMed ID: 30097643
[TBL] [Abstract][Full Text] [Related]
14. The Alternating Access Mechanism in Mammalian Multidrug Resistance Transporters and Their Bacterial Homologs.
Badiee SA; Isu UH; Khodadadi E; Moradi M
Membranes (Basel); 2023 May; 13(6):. PubMed ID: 37367772
[TBL] [Abstract][Full Text] [Related]
15. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2.
Han B; Zhang JT
Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):31-42. PubMed ID: 14754410
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
Barrand MA; Bagrij T; Neo SY
Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
[TBL] [Abstract][Full Text] [Related]
18. The structure of the multidrug resistance protein 1 (MRP1/ABCC1). crystallization and single-particle analysis.
Rosenberg MF; Mao Q; Holzenburg A; Ford RC; Deeley RG; Cole SP
J Biol Chem; 2001 May; 276(19):16076-82. PubMed ID: 11279022
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of multidrug resistance-linked P-glycoprotein (ABCB1) function by 5'-fluorosulfonylbenzoyl 5'-adenosine: evidence for an ATP analogue that interacts with both drug-substrate-and nucleotide-binding sites.
Ohnuma S; Chufan E; Nandigama K; Jenkins LM; Durell SR; Appella E; Sauna ZE; Ambudkar SV
Biochemistry; 2011 May; 50(18):3724-35. PubMed ID: 21452853
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
